AIDS trials take on peer review

Article Abstract:

Members of the AIDS Clinical Trials Group (ACTG) charge that the group subverted its own process to ensure that a Harvard AIDS trial site would be funded. ACTG had planned to fund the 1st 29 sites, which excluded 27th-ranked Harvard, until a 'second layer' of peer review decided to fund 30 groups.

Management, Finance, Clinical trials, United States. National Institute of Allergy and Infectious Diseases, Federal aid to medical research, Medical research assistance

---

Somber news from the AIDS front

Article Abstract:

The AIDS conference focused on the expanding epidemic and the poor performance of anti-AIDS drugs. Hopeful studies presented included stemming the spread of AIDS by preventing other social diseases and vaccines based on cell-mediated immunity in healthy HIV-infected people.

Sexually transmitted diseases, Care and treatment, AIDS vaccines, Cellular immunity

---

Similar abstracts:

• Abstracts: AIDS drug trials enter new age. New AIDS drugs take careful aim. Trials and tribulations of AIDS drug testing
• Abstracts: Oregon puts bold health plan on ice. Oregon's plan comes to the capital. Listing to starboard: the Oregon formula
• Abstracts: Supercritical carbon dioxide extraction of organics from soil. Investigation of adsorption equilibria of volatile organics on soil by frontal analysis chromatography
• Abstracts: Predator-free guppies take an evolutionary leap forward. Fossilized hatchling heats up the bird-dinosaur debate
• Abstracts: Superconductivity goes to sea. Molecular marvels: the next industrial revolution will come when tiny machines start building everything a molecule at a time

This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.